Acura Pharmaceuticals, Inc. (ACUR) Swings to Q2 Loss of 5c/Share

Acura Pharmaceuticals, Inc. (NASDAQ: ACUR) reported Q2 EPS of ($0.05), versus $0.35 reported last year.

For earnings history and earnings-related data on Acura Pharmaceuticals, Inc. (ACUR) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Okta upgraded as AI security opportunity boosts outlook
• On Holding AG (ONON) PT Lowered to $73 at UBS on Short-Term Industry Dynamics
• Bernstein SocGen on Intuitive Surgical (ISRG): 'We see $400 as a great entry point'